Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2021

01-03-2021 | Metastasis | Case Report

An Uncommon Cause of Hematochezia

Authors: Rizwan Ishtiaq, Muhammad Aziz, Darlene M. Wilhelm, Vinaya V. Gaduputi, Syed Uzair Hamdani

Published in: Journal of Gastrointestinal Cancer | Issue 1/2021

Login to get access

Excerpt

A diagnosis of pancreatic cancer carries a very poor prognosis and is the fourth leading cause of cancer-related mortality in developed nations [1]. In the USA, pancreatic cancer accounts for almost 3% of all the cancers and almost 7% of all cancer deaths [2]. The poor prognosis associated with pancreatic cancer is directly related to the timing of diagnosis which frequently occurs when the cancer is already in an advanced stage with approximately 50% of the patients having metastasis at the time of diagnosis and only 20% having resectable tumors [3]. Common sites for metastasis of pancreatic cancer include the liver, peritoneum, lungs, and lymph nodes. Rarely, pancreatic cancer metastasizes to the colon [1]. This case report highlights an occurrence of pancreatic adenocarcinoma with metastasis to the colon that presented clinically as hematochezia. An extensive literature search found only nine cases of colonic metastasis from primary pancreatic cancer. We did not include cases which involved direct extension of the pancreatic lesion into the colonic mass or cancers involving pancreatobiliary systems in our review. Our case is unique in a sense that it is the second reported case in literature which initially presented with hematochezia and was ultimately found to be pancreatic cancer with metastasis to the colon. …
Literature
1.
go back to reference Kim W, Lee Y. Metachronous colonic metastasis from pancreatic cancer presenting as mechanical obstruction: a case report. Clin Imaging. 2015;39(4):699–701.CrossRef Kim W, Lee Y. Metachronous colonic metastasis from pancreatic cancer presenting as mechanical obstruction: a case report. Clin Imaging. 2015;39(4):699–701.CrossRef
2.
go back to reference American Cancer Society. Facts & Figures 2019. American Cancer Society, Atlanta; 2019. American Cancer Society. Facts & Figures 2019. American Cancer Society, Atlanta; 2019.
3.
go back to reference Huguet F, Mukherjee S, Javle M. Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy. Clin Oncol. 2014;26(9):560–8.CrossRef Huguet F, Mukherjee S, Javle M. Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy. Clin Oncol. 2014;26(9):560–8.CrossRef
4.
go back to reference Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Case report metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Case report metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral
5.
go back to reference Nogueira ST, Pinto BL, Silva EF, Garcia HA, Carneiro F. Pancreatic cancer presenting as colonic disease. A rare case report. Int J Surg Case Rep. 2018;44:4–7.CrossRef Nogueira ST, Pinto BL, Silva EF, Garcia HA, Carneiro F. Pancreatic cancer presenting as colonic disease. A rare case report. Int J Surg Case Rep. 2018;44:4–7.CrossRef
6.
go back to reference Inada K, Shida D, Noda K, Inoue S, Warabi M, Umekita N. Metachronous colonic metastasis from pancreatic cancer seven years post-pancreatoduodenectomy. World J Gastroenterol: WJG. 2013;19(10):1665–8.CrossRef Inada K, Shida D, Noda K, Inoue S, Warabi M, Umekita N. Metachronous colonic metastasis from pancreatic cancer seven years post-pancreatoduodenectomy. World J Gastroenterol: WJG. 2013;19(10):1665–8.CrossRef
7.
go back to reference Bellows C, Gage T, Stark M, McCarty C, Haque S. Metastatic pancreatic carcinoma presenting as colon carcinoma. South Med J. 2009;102(7):748–50.CrossRef Bellows C, Gage T, Stark M, McCarty C, Haque S. Metastatic pancreatic carcinoma presenting as colon carcinoma. South Med J. 2009;102(7):748–50.CrossRef
8.
go back to reference Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral
9.
go back to reference Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):1–5.CrossRef Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):1–5.CrossRef
10.
go back to reference Gizzi G, Santini D, Golfieri R, Fuccio L. Diffuse colonic metastases from primary pancreatic cancer. Gastrointest Endosc. 2017;85(3):678–9.CrossRef Gizzi G, Santini D, Golfieri R, Fuccio L. Diffuse colonic metastases from primary pancreatic cancer. Gastrointest Endosc. 2017;85(3):678–9.CrossRef
11.
go back to reference Lee P, Sutherland D, Feller ER. Massive gastrointestinal bleeding as the initial manifestation of pancreatic carcinoma. Int J Pancreatol. 1994;15(3):223–7.PubMed Lee P, Sutherland D, Feller ER. Massive gastrointestinal bleeding as the initial manifestation of pancreatic carcinoma. Int J Pancreatol. 1994;15(3):223–7.PubMed
12.
go back to reference Ogu US, Bloch R, Grace Park BAMS. A rare case of metachronous skip metastasis of pancreatic cancer to the colon. Am Surg. 2012;78(7):E342.CrossRef Ogu US, Bloch R, Grace Park BAMS. A rare case of metachronous skip metastasis of pancreatic cancer to the colon. Am Surg. 2012;78(7):E342.CrossRef
13.
go back to reference Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):99.CrossRef Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):99.CrossRef
14.
go back to reference Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system: International Agency for Research on Cancer; 2010. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system: International Agency for Research on Cancer; 2010.
15.
go back to reference Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas: Elsevier Health Sciences; 2009. Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas: Elsevier Health Sciences; 2009.
16.
go back to reference Yokota T, Kunii Y, Kagami M, Yamada Y, Takahashi M, Kikuchi S, et al. Metastatic breast carcinoma masquerading as primary colon cancer. Am J Gastroenterol. 2000;95(10):3014–6.CrossRef Yokota T, Kunii Y, Kagami M, Yamada Y, Takahashi M, Kikuchi S, et al. Metastatic breast carcinoma masquerading as primary colon cancer. Am J Gastroenterol. 2000;95(10):3014–6.CrossRef
17.
go back to reference Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174(2):169–74.CrossRef Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174(2):169–74.CrossRef
18.
go back to reference Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.CrossRef Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.CrossRef
19.
go back to reference Voravud N, El-Naggar AK, Balch CM, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992;15(4):365–9.CrossRef Voravud N, El-Naggar AK, Balch CM, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992;15(4):365–9.CrossRef
20.
go back to reference Conroy T, Bachet JB, Ayav A, Huguet F, Lambert A, Caramella C, et al. Current standards and new innovative approaches for treatment of pancreatic cancer. Eur J Cancer. 2016;57:10–22.CrossRef Conroy T, Bachet JB, Ayav A, Huguet F, Lambert A, Caramella C, et al. Current standards and new innovative approaches for treatment of pancreatic cancer. Eur J Cancer. 2016;57:10–22.CrossRef
21.
go back to reference Cascinu S, Falconi M, Valentini VI, Jelic S, ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl_5):v55–8.CrossRef Cascinu S, Falconi M, Valentini VI, Jelic S, ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl_5):v55–8.CrossRef
Metadata
Title
An Uncommon Cause of Hematochezia
Authors
Rizwan Ishtiaq
Muhammad Aziz
Darlene M. Wilhelm
Vinaya V. Gaduputi
Syed Uzair Hamdani
Publication date
01-03-2021
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2021
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00470-4

Other articles of this Issue 1/2021

Journal of Gastrointestinal Cancer 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine